SCHEMBL1022941

SCHEMBL1022941

CCCCCCc1cc(CC)c(O)c(CCCCCC)c1

nearest known ligand 0.58

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PTGS2 P35354 7/20 0.58
CYP3A4 P08684 3/20 0.55
ALOX5 P09917 5/20 0.50
GPR84 Q9NQS5 2/20 0.49
ESR1 P03372 2/20 0.48
ADRA2A P08913 2/20 0.48
ADORA3 P0DMS8 2/20 0.48
TACR2 P21452 2/20 0.48
SLC6A2 P23975 2/20 0.48
SLC6A4 P31645 2/20 0.48
SLC6A3 Q01959 2/20 0.48
TP53 P04637 2/20 0.48
KDM4E B2RXH2 1/20 0.48
ALDH1A1 P00352 1/20 0.48
LMNA P02545 1/20 0.48
SHBG P04278 1/20 0.48
HSPD1 P10809 1/20 0.48
ADRB3 P13945 1/20 0.48
HTR2C P28335 1/20 0.48
HSPE1 P61604 1/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11811106 1.00 PTGS2 (0.58) PTGS2CYP3A4ALOX5GPR84ESR1
SCHEMBL1020425 1.00 PTGS2 (0.58) PTGS2CYP3A4ALOX5GPR84ESR1
SCHEMBL1022144 1.00 PTGS2 (0.58) PTGS2CYP3A4ALOX5GPR84ESR1
SCHEMBL1023311 1.00 PTGS2 (0.58) PTGS2CYP3A4ALOX5GPR84ESR1
SCHEMBL1024228 1.00 PTGS2 (0.58) PTGS2CYP3A4ALOX5GPR84ESR1
SCHEMBL1022467 1.00 PTGS2 (0.58) PTGS2CYP3A4ALOX5GPR84ESR1
SCHEMBL1023220 1.00 PTGS2 (0.58) PTGS2CYP3A4ALOX5GPR84ESR1
SCHEMBL1022950 0.98 PTGS2 (0.56) PTGS2CYP3A4ALOX5GPR84ESR1
SCHEMBL1023494 0.98 PTGS2 (0.56) PTGS2CYP3A4ALOX5GPR84ESR1
SCHEMBL1021887 0.98 PTGS2 (0.56) PTGS2CYP3A4ALOX5GPR84ESR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-101589022-B Method for producing isocyanate ASAHI KASEI CHEMICALS CORP 2013-08-14 CN disclosed
CN-101600684-B Process for producing isocyanate ASAHI KASEI CHEMICALS CORP (JP) 2013-03-06 CN disclosed
US-8053595-B2 Process for producing isocyanates ASAHI KASEI CHEMICALS CORPORATION (JP) 2011-11-08 US disclosed
EP-2088137-B1 A PROCESS FOR PRODUCING ISOCYANATES ASAHI KASEI CHEMICALS CORP (JP) 2011-01-12 EP disclosed
US-20100029981-A1 PROCESS FOR PRODUCING ISOCYANATES ASAHI KASEI CHEMICALS CORPORATION (JP) 2010-02-04 US disclosed
EP-2088137-A1 METHOD FOR PRODUCING ISOCYANATE Asahi Kasei Chemicals Corporation (JP) 2009-08-12 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100029981-A1 PROCESS FOR PRODUCING ISOCYANATES PAH, ALKBH3, GRHPR PTGS2 1130/4885CYP3A4 106/4885ALOX5 810/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.